Blood Bank Guy Essentials Podcast 094CE: Thalassemia Essentials with Sujit Sheth
Mar 2, 2022
Sujit Sheth, a pediatric hematologist and director at the New York Comprehensive Thalassemia Center, shares insights into thalassemia, a significant yet often overlooked global health issue. He discusses the differences in treatment compared to sickle cell disease and emphasizes the complexities of managing this genetic disorder. The conversation covers red cell transfusion strategies, the importance of maintaining optimal hemoglobin levels, and advances like gene therapy. Sheth highlights education's role in improving awareness and care for thalassemia patients.
AI Snips
Chapters
Transcript
Episode notes
Thalassemia Is A Quantitative Globin Problem
- Hemoglobin is built from alpha and beta globin chains; fetal hemoglobin uses gamma instead of beta.
- Thalassemia arises when one chain type is underproduced, causing quantitative imbalance and disease.
Key Difference: Effective Vs Ineffective Erythropoiesis
- Sickle cell is a qualitative defect (abnormal beta chain) with effective erythropoiesis, while thalassemia is quantitative with ineffective erythropoiesis.
- Ineffective erythropoiesis in thalassemia underlies marrow expansion, organomegaly, bone disease, and iron overload.
Molecular Cascade Explains Bone And Organ Changes
- Excess alpha tetramers form hemichromes that damage precursors, causing apoptosis and marrow expansion.
- Marrow expansion explains skull/face deformities, hepatosplenomegaly, and extramedullary masses in untreated patients.